A5103203395- Autoimmune Bullous Skin Diseases
- Dermatology and Skin Diseases
- Psoriasis: Treatment and Pathogenesis
- Infectious Diseases and Mycology
- Dermatological diseases and infestations
- CAR-T cell therapy research
- Vascular Malformations Diagnosis and Treatment
- Research on Leishmaniasis Studies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Fungal Infections and Studies
- Vascular Malformations and Hemangiomas
- Urticaria and Related Conditions
- Genetic and rare skin diseases.
- Patient-Provider Communication in Healthcare
- Cutaneous lymphoproliferative disorders research
- Beetle Biology and Toxicology Studies
University of Verona
2018-2021
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2014-2015
University of Milan
2014
Chronic spontaneous urticaria (CSU) is defined as occurrence of wheals and/or angioedema for ≥6 weeks. Omalizumab a monoclonal anti-IgE antibody effective in refractory CSU, but its mechanism action and markers predictive response remain not completely defined.To correlate baseline levels two proposed biomarkers, total IgE (bIgE) d-dimer (bd-dimer), clinical parameters to omalizumab relapses after drug withdrawal.In this retrospective Italian multicentre study, data were collected 470 CSU...
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...
Secukinumab is administered at the labelled dose of 300 mg weeks 0, 1, 2, 3, 4 (loading dose) and every thereafter.To investigate efficacy secukinumab without initial loading in patients with psoriasis.This was a retrospective observational study including adult psoriasis (n = 156) treated either according to 75) or 81). Efficacy evaluated by comparing Psoriasis Area Severity Index (PASI) 75 PASI 90 response rates week 8, 12, 16, 32 48.For who received vs. those did not, were achieved 48 60%...
Mycosis fungoides is predominantly a disease of older patients, but occasionally occurs in children. We report rare case CD8+/CD56+ mycosis with cytotoxic marker (perforin, TIA‐1, and granzyme B) expression 10‐year‐old boy. Disease presented three asymptomatic, slowly progressive erythematous scaling plaques, surrounded by hypochromic alone the left tight lower trunk. UVB narrow band associated topical corticosteroids resulted complete remission about 2 months, no recurrence at 2‐year...
In psoriasis patients, satisfaction and patients' attitude toward treatment are heterogeneous depending on several factors remain poorly investigated, although the availability of new targeted therapeutic options. A multicentre cross-sectional investigation was conducted to estimate attitudes (awareness, trust, alliance) in a large population adult patients undergoing systemic biologic or non-biologic agent for moderate-to-severe plaque-type psoriasis. Patients' measured using Treatment...